Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Clinical trial NCT00301795 · TERMINATED

Trial details

NCT number: NCT00301795
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma

Start date: 2006-03-01
Primary completion: 2007-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.